Contract facts
UnrestrictedNo full NAICS 541380 intel page yet. Browse NAICS intelligence
NCI - CORRECTIVE EDITING OF SPLICING FACTOR MUTANT MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA is a federal Unrestricted award for National Institutes Of Health Olao held by H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. Estimated value $148K ($148K obligated). Current period of performance ends Jul 12, 2027. Last award drew 1 bidder. Place of performance: BETHESDA MD.
NCI - CORRECTIVE EDITING OF SPLICING FACTOR MUTANT MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA
Recompete timing
PublicCurrent PoP ends Jul 12, 2027 (293 days remaining). Agencies typically plan 12–18 months ahead — at 9.6 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75N98026P00992? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordH. Lee Moffitt Cancer Center and Research Institute Hospital, Inc — $1.1M obligated across 12 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N98026P00992?
75N98026P00992 (NCI - corrective editing of splicing) is a National Institutes Of Health Olao award with a potential value of $148K, currently held by H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N98026P00992?
National Institutes Of Health Olao awarded 75N98026P00992 to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc (potential $148K).
Who is the incumbent on 75N98026P00992?
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc is the incumbent with $1.1M across 12 related awards in SCOUT’s public footprint. The current period of performance ends Jul 12, 2027.
When does H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc’s 75N98026P00992 come up for recompete?
SCOUT tracks a period-of-performance end of Jul 12, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N98026P00992? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.